The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats
- 1 October 1985
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 34 (10) , 885-892
- https://doi.org/10.1016/0026-0495(85)90133-7
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Determination of Tolrestat, a Novel Aldose Reductase Inhibitor, in Serum and TissuesTherapeutic Drug Monitoring, 1984
- Aldose and aldehyde reductases in human tissuesBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Red blood cell sorbitol as an indicator of polyol pathway activity. Inhibition by sorbinil in insulin-dependent diabetic subjectsDiabetes, 1984
- Sorbitol Concentration in the Plasma and Erythrocytes of Diabetic SubjectsDiabetes Care, 1982
- Some effects of aldose reductase inhibition upon the eyes of long-term streptozotocin-diabetic ratsCurrent Eye Research, 1982
- Clinical trial of an aldose reductase inhibitor in diabetic neuropathyDiabetes, 1981
- Diabetic Cataracts and FlavonoidsScience, 1977
- The Reduction of Glyceraldehyde by Human Erythrocytes L-HEXONATE DEHYDROGENASE ACTIVITYJournal of Clinical Investigation, 1974
- Glucose utilization by the polyol pathway in human erythrocytesBiochemical and Biophysical Research Communications, 1970
- The distribution of polyol:NADP oxidoreductase in mammalian tissuesBiochemical and Biophysical Research Communications, 1969